Retraction Note: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
Critical Care volume 27, Article number: 146 (2023)
Retraction Note: Critical Care 2012, 16:R32 https://doi.org/10.1186/1364-8535-16-R32
The Editor in Chief retracted this article because of significant concerns regarding the Western blots in Figs. 2A–F and 3A–D which question the integrity of the data. The authors stated that some of these figures were created by cutting and splicing blots to show representative samples. However, the authors were unable to supply raw images or explain the similarity in appearance of the figures. The Editor-in-Chief therefore no longer has confidence in the integrity of the data in this article. Alessandra Bitto and Francesco Squadrito do not agree to this retraction. Letteria Minutoli, Antonio David and Natasha Irrera had not responded to correspondence from the editor about this retraction. The editor was not able to obtain a current email address for Mariagrazia Rinaldi and Francesco S. Venuti. Allessandra Bitto has stated that Domenica Altavilla is now deceased.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bitto, A., Minutoli, L., David, A. et al. Retraction Note: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. Crit Care 27, 146 (2023). https://doi.org/10.1186/s13054-023-04440-7